Ultralife Corporation
ULBI
$5.68
-$0.09-1.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.51% | 12.98% | 21.03% | -1.56% | -9.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.51% | 12.98% | 21.03% | -1.56% | -9.61% |
| Cost of Revenue | 24.95% | 17.57% | 24.57% | 0.32% | -9.09% |
| Gross Profit | 10.79% | 0.50% | 11.64% | -7.04% | -11.17% |
| SG&A Expenses | 22.35% | 21.97% | 20.63% | 17.96% | 0.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.18% | 18.13% | 24.56% | 4.23% | -6.48% |
| Operating Income | -146.91% | -38.40% | -11.79% | -66.46% | -64.36% |
| Income Before Tax | -596.03% | -71.06% | -32.19% | -84.10% | -79.82% |
| Income Tax Expenses | -781.08% | -71.51% | -19.35% | -0.38% | -83.41% |
| Earnings from Continuing Operations | -546.95% | -70.93% | -35.30% | -91.82% | -78.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 228.57% | 137.50% | -7.69% | -269.57% | -177.78% |
| Net Income | -572.87% | -70.39% | -35.49% | -93.25% | -80.60% |
| EBIT | -146.91% | -38.40% | -11.79% | -66.46% | -64.36% |
| EBITDA | -39.49% | -22.34% | -1.83% | -47.93% | -43.79% |
| EPS Basic | -572.90% | -70.54% | -36.42% | -93.34% | -81.07% |
| Normalized Basic EPS | -295.33% | -66.36% | -28.31% | -88.76% | -68.99% |
| EPS Diluted | -572.90% | -72.10% | -37.61% | -93.70% | -80.63% |
| Normalized Diluted EPS | -298.10% | -65.91% | -28.00% | -88.83% | -69.29% |
| Average Basic Shares Outstanding | 0.13% | 0.40% | 1.45% | 1.78% | 2.38% |
| Average Diluted Shares Outstanding | -1.35% | -1.00% | 0.98% | 1.72% | 3.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |